Natural isoquinoline alkaloids such as berberine and chelerythrine exhibit a variety of biological activities. 1, 2 Berberine has been isolated from several medicinal herbs, such as Hydrastis canadensis, Cortex phellodendri and Rhizoma coptidis which are widely distributed in plants and used as the traditional oriental medicine. Recently it has been attracted by the unique biological activities such as antidiabetic, 3 anticancer 4, 5 and antimicrobial activities. 6, 7 One of the most interesting properties of berberine is that it exhibits cholesterol-lowering effect. 8, 9 Oral administration of berberine in 32 hypercholesterolemic patients for 3 months reduced serum cholesterol by 29%, triglycerides by 35% and LDL-cholesterol by 25%. 9 Emerging of this compound as new cholesterol-lowering drug prompted us to develop new efficient synthesis of berberine.
Chelerythrine, a benzo[c]phenanthridine alkaloid, also has been investigated for its biological efficacy such as antitumor, 10 inhibition of protein kinase C, 11 induction of apoptosis through the generation of reactive oxygen and the stimulation of GSH transport. 12 Due to the interesting biological activities, the synthesis of protoberberine and benzo[c]phenanthridines has been studied. 1, 13, 14 Recently, we have also reported a versatile synthetic pathways for these alkaloids using lithiated toluamidebezonitrile cycloaddition. 15, 16 As depicted in Scheme 1, benzo[c]phenanthridine alkaloid, chelerythrine, was proposed to be biosynthesized from the corresponding protoberberine alkaloid. 17 In this pathway, the 3-arylisoquinolinone is a key intermediate for the cyclization step toward the benzo[c]phenanthridine skeleton.
We have reported the synthesis and QSAR studies of 3-arylisoquinoline derivatives with antitumor activity. [17] [18] [19] [20] The synthetic strategy involved in the coupling reaction of Nmethyl-o-toluamide with benzonitrile derivatives. Retrosynthetic analysis of both alkaloids suggested that the coupling reaction of o-toluamide 1 with benzonitrile 2 affords 3-arylisoquinoline 3, which could be converted to 8-oxoberberine 4 via S N 2 type cyclization of amide nitrogen. On the other hand, cyclization at C4 position could give oxychelerythrine 5 as shown in Scheme 2.
N-Methyl-o-toluamide 1 22 was lithiated with n-butyl lithium to give the dianion, which was treated with benzonitrile 2 15 at -50 o C in THF to afford the 3-arylisoquinoline-1(2H)-one 6. Deprotection of MOM (methoxymethyl) with 10% HCl gave the alcohol 7, which were then reacted with p-TsCl in DMF in the presence of triethylamine to afford the desired protoberberine alkaloid, oxyberberine 4 in 63% yield (Scheme 3).
The 3-arylisoquinoline intermediate 6 was treated with MeI/K 2 CO 3 provided the N-methylated product 8 without yielding O-methylated compounds in 61% yield. Hydrolysis of MOM group with 10% HCl gave the alcohols 9 which was then oxidized with PCC/NaOAc to provide the desired benzo[c]phenanthridine alkaloid, oxychelerythrine 5 in 65% yield (Scheme 4).
In conclusion, we accomplished a biomimetic synthesis of 8-oxoberberine 4 and oxychelerythrine 5 in three and four steps, respectively. Efficiency and short synthetic step made this process possible to be used as a general method for multi gram scale preparation of these alkaloids.
Experimental Section
Melting points were determined by using the capillary method on Electrothermal IA9200 digital melting point apparatus and were uncorrected. Nuclear magnetic resonance (NMR) data for 1 H NMR was taken on Varian Unity 300 plus spectrometer and were reported in ppm, downfield from the peak of tetramethylsilane as an internal standard. The data are reported as follows: chemical shift, number of proton, multiplicity (s: singlet, d: doublet, t: triplet, q: quartet, m: multiplet). IR spectra were recorded on JASCO-FT IR spectrometer using CHCl 3 and KBr pellets. Mass spectra were obtained on JEOL JNS-DX 303 applying the electronimpact (EI) method. Column chromatography was performed on Merck silica gel 60 (70-230 mesh). TLC was carried out using plates coated with silica gel 60 F254 purchased from Merck. Chemical reagents were purchased from Aldrich Chemical Co. and used without further purification. Solvents were distilled prior to use: THF, ether were distilled from 
3-[6-(2-Hydroxyethyl)benzo[1,3]dioxol-5-yl]-7,8-dimethoxy-2H-isoquinolin-1-one (7)
. To a solution of compound 6 (450 mg, 1.09 mmol) in THF (15 mL) was added 10% HCl (5 mL) and then the reaction mixture was refluxed for 2 h. It was poured into water and extracted with ethyl acetate. The ethyl acetate extract was washed with water, brine and dried over anhydrous sodium sulfate. After removing the solvent, the residue was purified by column chromatography on silica gel with CH2Cl2 : MeOH The reaction mixture of alcohol 9 (70 mg, 0.18 mmol), PCC (80 mg, 0.37 mmol) and NaOAc (25 mg, 0.3 mmol) in CH2Cl2 (8 mL) was stirred for 5 h. The reaction mixture was filtered and the filtrate was washed with CH2Cl2. The combined solvents were evaporated off and the residue was purified by column chromatography on silica gel with nhexane-ethyl acetate (1 : 1) to afford the oxychelerythrine 5 as a white solid (42 mg, 65% 
